US Food and Drug Administration (FDA) grants Breakthrough Device status to Guerbet innovation: DUOnco Pancreas for early detection of pancreatic lesions
20 3 月 2025
Guerbet (FR0000032526 GBT), a world leader in medical i […]
Guerbet, Intrasense, Gustave Roussy and the University Hospital of Angers receive a €5.9M financing from Bpifrance for Liflow®, innovative solution dedicated to oncology imaging
3 12 月 2024
Guerbet (FR0000032526 GBT) worldwide expert in contrast […]